Akoya Biosciences Inc

85 articles about Akoya Biosciences Inc

• Akoya Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

  1/4/2022

  Akoya Biosciences, Inc. today announced that it will be virtually participating in the 40th Annual J.P. Morgan Healthcare Conference.

• Akoya Biosciences Unveils Comprehensive Roadmap of Innovations at Inaugural Spatial Day Event

  12/15/2021

  Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today unveiled its next-generation of innovations to enable unbiased spatial phenotyping at unprecedented speeds, setting a new standard in spatial biology.

• Akoya Biosciences Announces a Groundbreaking Collaboration with PathAI to Combine Spatial Biology with AI-Powered Tools to Facilitate Discovery of Novel Predictive Biomarkers

  12/13/2021

  Akoya Biosciences, Inc. today announced a collaboration to advance the discovery and validation of novel predictive biomarkers for immunotherapies.

• Akoya Biosciences Secures CLIA Lab Certification, a Milestone for Applying Its Spatial Biology Technologies to Accelerating Precision Cancer Therapies

  11/30/2021

  Akoya Biosciences, Inc., The Spatial Biology Company®, announced that its Advanced Biopharma Solutions laboratory, located in Marlborough, Massachusetts, has received its Certificate of Registration from the Clinical Laboratory Improvement Amendments program, following the receipt of a Massachusetts Department of Public Health clinical laboratory license.

• Akoya Biosciences to Host Inaugural Spatial Day on December 15, 2021

  11/22/2021

  Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will host an inaugural Spatial Day on December 15, 2021 at 12 p.m. ET.

• Akoya Biosciences to Present Data at SITC 2021 Highlighting Novel Spatial Biology Applications

  11/4/2021

  Akoya Biosciences Inc., The Spatial Biology Company®, announced that new data generated with its CODEX® and Phenoptics™ platforms will be presented at the 35th Annual Meeting of the Society for Immunotherapy of Cancer, taking place November 10-14 virtually and at the Walter E. Washington Convention Center in Washington, DC.

• Akoya to Participate at Two Upcoming Investor Conferences in November

  11/3/2021

  Akoya Biosciences, Inc. today announced that it will be virtually participating in two upcoming investor conferences.

• Akoya Biosciences Announces Founding Members of First-of-its-Kind Imaging Innovators (I²) Network

  11/2/2021

  Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company ® , today announced the first members of the Akoya Imaging Innovators (I² ) Network , a collaboration of pioneering scientists from world-class research organizations, with ambitions to advance the field of spatial biology.

• Akoya Biosciences Appoints Pascal Bamford, PhD, as SVP, R&D and Laboratory Operations

  10/26/2021

  Akoya Biosciences, Inc. (NASDAQ: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Pascal Bamford, PhD, as Senior Vice President, Research and Development and Laboratory Operations.

• Akoya to Report Third Quarter 2021 Financial Results on November 8th, 2021

  10/19/2021

  Akoya Biosciences, Inc. today announced that it will release financial results for the third quarter of 2021 after the market close on Monday, November 8th , 2021.

• Akoya Biosciences Appoints Diagnostics Industry Pioneer Myla Lai-Goldman, MD, to its Board of Directors

  9/22/2021

  Akoya Biosciences, Inc. (NASDAQ: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Myla Lai-Goldman, MD, a true pioneer and leader in the diagnostic industry, to its board of directors.

• Akoya Biosciences to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

  8/31/2021

  Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be virtually participating in the Morgan Stanley 19th Annual Global Healthcare Conference.

• Akoya Reports 53% Revenue Growth in the Second Quarter of 2021

  8/10/2021

  Akoya Biosciences, Inc.Akoya Biosciences, Inc., The Spatial Biology Company®, announced its financial results for the second quarter ending June 30, 2021.

• Akoya Biosciences to Present at the Canaccord 41st Annual Growth Conference

  8/3/2021

  Akoya Biosciences, Inc., The Spatial Biology Company®, announced that it will be virtually participating in the Canaccord 41st Annual Growth Conference.

• Akoya to Report Second Quarter 2021 Financial Results on August 10, 2021

  7/20/2021

  Akoya Biosciences, Inc. today announced that it will release financial results for the second quarter of 2021 after the market close on Tuesday, August 10, 2021.

• Akoya Announces Publication of the MITRE Study, the First Multi-Institutional Analytical Demonstration of a Spatial Biology Workflow, in the Journal for ImmunoTherapy of Cancer

  7/19/2021

  Akoya Biosciences, Inc. today announced that the Phenoptics™ mIF solution was used in a multi-site study to demonstrate and validate an automated end-to-end workflow that characterizes PD-1/PD-L1 immune checkpoint signaling in tumor tissue samples.

• Akoya to Partner with Nikon, CrestOptics and Andor to Enable New Spatial Biology Applications through the Imaging Innovators (I2) Network

  6/29/2021

  Akoya Biosciences Inc. today announced partnerships with premier microscope providers, Nikon, CrestOptics, and Andor to enable the development of new spatial biology applications, through the recently announced I 2 Network

• Akoya Biosciences Appoints Diagnostics Industry Leader Scott Mendel to its Board of Directors

  6/25/2021

  Akoya Biosciences Inc., (NASDAQ: AKYA), The Spatial Biology Company ® , today announced the appointment of diagnostics industry leader Scott Mendel to its board of directors.

• Akoya to Help Support Leading Philanthropic Organization with Spatial Phenotyping Capabilities

  6/15/2021

  Akoya Biosciences, Inc., The Spatial Biology Company®, announced that it will be offering the CODEX® solution’s single-cell, whole-tissue imaging capabilities to the Chan Zuckerberg Initiative’s grantees, under favorable commercial terms.

• Akoya Announces Publication of New Immunotherapy Biomarker Signature in Science, Leveraging Principles of Astronomy and Pathology

  6/10/2021

  Akoya Biosciences Inc., announced today that its Phenoptics solution contributed to the successful development of a novel platform, titled AstroPath.